Quick Answer
Harmony Biosciences Holdings, Inc. reported Total Revenue of $868.45 million for fiscal year 2025.
Harmony Biosciences Holdings, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $868.45M | +21.5% |
| 2024 | $714.73M | +22.8% |
| 2023 | $582.02M | +32.9% |
| 2022 | $437.86M | +43.4% |
| 2021 | $305.44M | +91.2% |
| 2020 | $159.74M | +2564.6% |
| 2019 | $6.00M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $239.46M | +28.7% | +19.4% |
| June 30, 2025 | $200.49M | +16.0% | +8.5% |
| March 31, 2025 | $184.73M | +19.5% | -0.7% |
| September 30, 2024 | $186.04M | +16.1% | +7.7% |
| June 30, 2024 | $172.81M | +28.8% | +11.8% |
| March 31, 2024 | $154.62M | +29.8% | -3.5% |
| September 30, 2023 | $160.27M | +36.7% | +19.4% |
| June 30, 2023 | $134.22M | +25.4% | +12.7% |
- Harmony Biosciences Holdings, Inc. showed an increase of +21.5% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, Harmony Biosciences Holdings, Inc.’s total revenue has grown by 14386.3% (from $6.00 million to $868.45 million).
- The most recent figure is from Harmony Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: